novo nordisk weight loss - Search News

News

Novo Nordisk to sell weight-loss drug for $499

Fox Business on MSN · 13h

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

Investopedia on MSN · 17h

Novo Nordisk's Weight-Loss Drug Wegovy Approved to Treat Liver Disease

Key Takeaways Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a serious disease of the liver.Wegovy can be used for patients suffering from noncirrhotic metabolic dysfunction-associated steatohepatitis,

Barron's on MSN · 10h

Wegovy News Pushes Novo Nordisk Stock Higher

Novo Nordisk stock rose after good news from the FDA on Wegovy—it’s popular weight-loss drug which has the same active indigent as diabetes treatment Ozempic.

3h

Novo Nordisk halves Ozempic price in US

The Ozempic price cut could appease US President Donald Trump, who has pushed for drug companies to lower their prices.

21h

Stocks to Watch Monday: Novo Nordisk, TeraWulf, UnitedHealth, Soho House

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results